What Due Diligence Misses, We Detect

A man in a suit sitting at a desk with a document, appearing thoughtful or worried, in a dimly lit office with large windows.

Business Intelligence for Biopharma

Precision. Insight. Integrity

At BBIU Global, we detect what traditional diligence cannot: structural, symbolic, and behavioral fractures that emerge after the deal is signed.

We surface what others miss—instability behind formal structures, drift disguised as strategy, compliance masking misalignment, and gaps between numbers and intent.

We don’t monitor performance. We monitor dissonance—using proprietary diagnostics like TEI™, EV™, and the C⁵ Coherence Framework™.

Born in Korean biopharma, now deployed worldwide. Built for LPs, CVCs, sovereign funds, acquirers—and strategic states.

Detecting fault lines before they become systemic. Engage us for a confidential integrity assessment.

Let's discuss a specific company or scenario

What Due Diligence Misses, We Detect

Precision. Insight. Integrity

At BBIU Global, we detect what traditional diligence cannot: structural, symbolic, and behavioral fractures that emerge after the deal is signed.

Detecting fault lines before they become systemic. Engage us for a confidential integrity assessment.

Work With Us.

Work With Us.

Interested in working together? Share your details and we’ll be in touch soon.

Biopharma Business Intelligence Unit (BBIU)